Estudo de coorte retrospectiva | Vacina da Pfizer reduz o risco de reinfecção após recuperação da Covid-19.
17 Fev, 2022 | 15:35hEffectiveness of the BNT162b2 Vaccine after Recovery from Covid-19 – New England Journal of Medicine
Comentário no Twitter
Among patients who had recovered from Covid-19, the receipt of at least one dose of the BNT162b2 vaccine was associated with a significantly lower risk of recurrent infection. https://t.co/AAlsY9sFlv pic.twitter.com/Nkj1lP77ZW
— NEJM (@NEJM) February 16, 2022